Zhejiang Yatai Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002370.SZ

Zhejiang Yatai Pharmaceutical Co., Ltd. Price to Book Ratio (P/B) on January 27, 2025: 4.03

Zhejiang Yatai Pharmaceutical Co., Ltd. Price to Book Ratio (P/B) is 4.03 on January 27, 2025, a 0.68% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Zhejiang Yatai Pharmaceutical Co., Ltd. 52-week high Price to Book Ratio (P/B) is 4.97 on December 09, 2024, which is 23.32% above the current Price to Book Ratio (P/B).
Zhejiang Yatai Pharmaceutical Co., Ltd. 52-week low Price to Book Ratio (P/B) is 2.38 on July 24, 2024, which is -41.03% below the current Price to Book Ratio (P/B).
Zhejiang Yatai Pharmaceutical Co., Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 3.37.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Shenzhen Stock Exchange: 002370.SZ

Zhejiang Yatai Pharmaceutical Co., Ltd.

CEO	Mr. Jianwei Cen
IPO Date	March 16, 2010
Location	China
Headquarters	No. 36, Nanbin West Road
Employees	528
Sector	Health Care
Industries Pharmaceuticals

Description

Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. It offers tablets, capsules, patches, powder injections, and troches. It also provides chemical agents and raw materials, and diagnostic reagents, as well as pharmaceutical research and development outsourcing services. Zhejiang Yatai Pharmaceutical Co., Ltd. was founded in 1989 and is based in Shaoxing, China.

Key trends

Past 5 years